United Therapeutics Wins Appeal In Dry Powder Inhaler Patent Litigation
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the United States Court of Appeals for the Federal Circuit affirmed the district court decision in the patent